Horace Mann Educators Corporation
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Horace Mann Educators Corporation.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 41.50 $ to 54.10 $ · Last price: 48.60 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Insurance - Property & Casualty
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Horace Mann Educators Corporation HMN | 1.9 | – | 0.0 | 39.5 | 13.9 | 4.8 | 9.4 |
| Chubb Ltd CB | 132.6 | 12.7 | 0.0 | 31.1 | 20.6 | 6.5 | 27.1 |
| Progressive Corp PGR | 126.0 | 11.7 | 21.9 | 18.5 | 16.4 | 16.3 | -5.5 |
| The Travelers Companies Inc TRV | 79.1 | 11.7 | 0.0 | 34.7 | 18.7 | 5.2 | 40.1 |
| The Allstate Corporation ALL | 64.9 | 5.9 | 0.0 | 36.8 | 19.0 | 4.6 | 30.3 |
| W. R. Berkley Corp WRB | 26.1 | 15.4 | 0.0 | 43.8 | 17.1 | 7.8 | -1.5 |
| Cincinnati Financial Corporation CINF | 25.8 | 10.1 | 0.0 | 31.1 | 11.8 | 11.4 | 13.9 |
| Markel Corporation MKL | 21.9 | 13.2 | 0.0 | 51.9 | -9.7 | -1.0 | -7.4 |
| Loews Corp L | 21.8 | 14.2 | 0.0 | 36.3 | 11.8 | 5.4 | 12.2 |
| Median of companies shown | 26.1 | 12.2 | 0.0 | 36.3 | 16.4 | 5.4 | 12.2 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 1,129 | 126 | 84 | 2.02 | 207 | 1,294 | 10,577 |
| 2017 | 1,172 | 101 | 169 | 4.07 | 257 | 1,502 | 11,198 |
| 2018 | 1,192 | 33 | 18 | 0.44 | 201 | 1,291 | 11,032 |
| 2019 | 1,405 | 236 | 184 | 4.40 | 128 | 1,567 | 12,479 |
| 2020 | 1,290 | 160 | 133 | 3.17 | 260 | 1,790 | 13,472 |
| 2021 | 1,250 | 210 | 170 | 4.04 | 205 | 1,807 | 14,384 |
| 2022 | 1,341 | 17 | 20 | 0.47 | 172 | 1,098 | 13,311 |
| 2023 | 1,433 | 53 | 45 | 1.09 | 302 | 1,175 | 14,050 |
| 2024 | 1,550 | 129 | 103 | 2.48 | 452 | 1,288 | 14,488 |
| 2025 | 1,625 | 201 | 162 | 3.90 | 553 | 1,483 | 15,267 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.92 | -3.30 | 393 | 2.30 | 9.70 | 194 | 194 |
| 2025: Q1 | 0.92 | 43.80 | 400 | 5.30 | 9.50 | 141 | 141 |
| 2025: Q2 | 0.71 | 673.70 | 392 | 3.30 | 7.50 | 131 | 131 |
| 2025: Q3 | 1.40 | 69.20 | 417 | 4.90 | 14.00 | 151 | 151 |
| 2025: Q4 | 0.87 | -5.50 | 419 | 6.60 | 8.60 | 130 | 130 |
| 2026: Q1 | 1.00 | 8.90 | 429 | 7.30 | 9.60 | 61 | 61 |
| 2026: Q2 | 1.01 | 42.30 | 444 | 13.30 | 9.40 | 224 | 224 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 12 of our scanner strategies — each hit links to the scanner.
Growth
Quality & Balance Sheet
Breakout & Setup
Dividends
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4.82 | 4.75 – 4.85 | 1,767 | 2.3% | 3 |
| 12/31/2027 | 5.30 | 5.10 – 5.40 | 2,070 | 10.0% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly -18.7% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $566.1M |
|---|---|
| Market cap | $1.90B |
| Free cash flow in year ten | $71.0M |
| Terminal value as a share of market value | 19.7% |
For comparison: over the past five years free cash flow grew by 9.1% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 6.6%
- More than 10% revenue growth is expected for the coming year 5.0%
- Share count grows by less than 3% a year -0.2%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 38.9%
- Gross margin at 40% or higher and without meaningful erosion 35.2%
- Goodwill from acquisitions does not grow faster than revenue 0.4%
- Net debt below twice EBITDA 41 m net cash
- Operating cash flow covers the profits of the last three years 998 m
- Return on capital at 15% or higher, or up versus two years ago no data
- Insiders hold at least 10% or are net buyers 1.6%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
7/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 4.1%
- Exp. sales growth 3Y > 5% 12.9%
- EBIT growth 10Y > 5% 5.3%
- Exp. EBIT growth 3Y > 5% 16.6%
- Net debt < 4x EBIT -0.2x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 93.0%
- Return on equity > 15% 17.5%
- ROCE > 15% –
- Expected return > 10% 50.6%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Carley Donald M | General Counsel | Sell | 2,054 | 52.28 | 107,385 |
| Sep 3, 2026 | Hines Perry G. | Director | Sell | 3,237 | 52.22 | 169,036 |
| Sep 1, 2026 | Zuraitis Marita | President & CEO | Sell | 7,500 | 50.99 | 382,425 |
| Aug 12, 2026 | Reece Henry Wade | Director | Sell | 1,359 | 51.52 | 70,018 |
| Aug 12, 2026 | Bradley Thomas A | Director | Sell | 5,000 | 51.72 | 258,623 |
| Aug 3, 2026 | Zuraitis Marita | President & CEO | Sell | 7,500 | 52.03 | 390,248 |
The company
About the Company
Horace Mann Educators Corporation ist gemeinsam mit ihren Tochtergesellschaften als Versicherungsholding in den USA tätig. Sie ist in drei Segmenten tätig: Property & Casualty, Life & Retirement und Supplemental & Group Benefits.
- CEO Insider Trades (12 Mo.)
- selling own stock
- Employees
- 1,800
- Headquarters
- Springfield, IL
- Address
- 1 Horace Mann Plaza, 62715-0001 Springfield, United States
- Phone
- 217 789 2500
- Website
- horacemann.com
- IPO Date
- 11/15/1991
- ISIN
- US4403271046
- Stock Split
- 2:1 on 12/16/1997
Management
| Name | Title | Birth Year |
|---|---|---|
| Marita Zuraitis | President, CEO & Director | 1960 |
| Ryan Edward Greenier | Executive VP & CFO | 1982 |
| Donald Martin Carley | Executive VP, General Counsel, Chief Administrative Officer & Corporate Secretary | 1968 |
| Mark Richard Desrochers | Senior VP & Chief Actuarial and Strategy Officer | 1969 |
| Maureen Temchuk | VP, Controller & Chief Accounting Officer | 1989 |
| Stephanie A. Fulks | Senior VP & Chief Information Officer | 1970 |
| Rachael Luber | Vice President of Investor Relations | – |
| Steven R. Chauby | Senior VP and Chief Marketing & Distribution Officer | 1982 |
| Jennifer Elaine Thayer | Senior VP & Chief Human Resources Officer | 1976 |
| D. Tyson Sanders | Senior Vice President of Individual Supplemental & Group Benefits | 1985 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 08/05/2026 HORACE MANN EDUCATORS CORP /DE/ (HMN): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
- 07/21/2026 HORACE MANN EDUCATORS CORP /DE/ (HMN): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits SEC ↗
- 07/21/2026 HORACE MANN EDUCATORS CORP /DE/ (HMN): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits SEC ↗
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.